GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SunLink Health Systems Inc (AMEX:SSY) » Definitions » EBITDA per Share

SunLink Health Systems (SunLink Health Systems) EBITDA per Share : $-0.28 (TTM As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is SunLink Health Systems EBITDA per Share?

SunLink Health Systems's EBITDA per Share for the three months ended in Dec. 2023 was $-0.02. Its EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.28.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for SunLink Health Systems's EBITDA per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of SunLink Health Systems was 115.90% per year. The lowest was -231.60% per year. And the median was -1.90% per year.

SSY's 3-Year EBITDA Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.7
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

SunLink Health Systems's EBITDA for the three months ended in Dec. 2023 was $-0.12 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of SunLink Health Systems was 95.10% per year. The lowest was -226.60% per year. And the median was 2.30% per year.


SunLink Health Systems EBITDA per Share Historical Data

The historical data trend for SunLink Health Systems's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SunLink Health Systems EBITDA per Share Chart

SunLink Health Systems Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 0.16 0.46 -0.55 -0.08

SunLink Health Systems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 -0.05 -0.20 -0.02 -0.02

SunLink Health Systems EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

SunLink Health Systems's EBITDA per Share for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA per Share(A: Jun. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=-0.557/7.019
=-0.08

SunLink Health Systems's EBITDA per Share for the quarter that ended in Dec. 2023 is calculated as

EBITDA per Share(Q: Dec. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=-0.115/7.040
=-0.02

EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SunLink Health Systems  (AMEX:SSY) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


SunLink Health Systems EBITDA per Share Related Terms

Thank you for viewing the detailed overview of SunLink Health Systems's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SunLink Health Systems (SunLink Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
900 Circle 75 Parkway, Suite 690, Atlanta, GA, USA, 30339
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
Executives
Howard E Turner director 135 PROVIDENCE OAKS POINTE, MILTON GA 30004
Thornton Robert M Jr director, officer: CEO & Chairman 900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
C Michael Ford director 310 NORRIS STREET, ST. MARYS GA 31558
Mills Christopher H B director 6 STRATTON STREET, MAYFAIR, LONDON X0 W1J 8LD
Steven J Baileys director 30691 HUNT CLUB DRIVE, SAN JUAN CAPISTRANO CA 92675
Sheila G. Brockman officer: CEO So Health Corp of Houston 900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
Mark J Stockslager officer: Corporate Controller and PAO 900 CIRCLE 75 PARKWAY STE. 690, ATLANTA GA 30339
Karen B Brenner director P.O. BOX 9109, NEWPORT BEACH CA 92658
Gene E Burleson director 320 ARGONNE DR, ATLANTA GA 30305-2814
A Ronald Turner officer: Chief Operating Officer 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Harry R Alvis officer: Chief Operating Officer 900 CIRCLE 75 PARKWAY STE. 1120, ATLANTA GA 30339
George D. Shaunnessy other: Pres/CEO Sunlink Homecare Svcs 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Jack M. Spurr officer: VP, Hospital Financial Ops. 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Michael William Hall director 3406 RAVENWOOD LANE, MIRAMAR BEACH FL 32550
North Atlantic Value Llp 10 percent owner RYDER COURT, 14 RYDER ST., LONDON A1 00000